Literature DB >> 23913108

Three dimensional anatomy of the human nucleus accumbens.

L Lucas-Neto1, D Neto, E Oliveira, H Martins, B Mourato, F Correia, A Rainha-Campos, A Gonçalves-Ferreira.   

Abstract

BACKGROUND: The Nucleus accumbens (Acc) is the main structure of the ventral striatum. It acts as a motor-limbic interface, being involved in emotional and psychomotor functions, frequently disturbed in neuropsychiatric disorders such as obsessive compulsive disorder and addiction. Most of the studies concerning the Acc were made in animals and those performed in humans are contradictory. Nevertheless, it has become a target for stereotactic deep brain stimulation for some of those diseases, when refractory to medical treatment. Previous studies performed by our group have established the localization, limits and dimensions of the human Acc and its stereotactic coordinates. Now it is our purpose to perform the Acc anatomical three-dimensional (3D) reconstruction in order to clarify its shape and topography and to render this nucleus a safer target for stereotactic procedures.
METHODS: Anatomical coronal slicing of ten Acc from human brains was performed, perpendicular to the anterior commissure-posterior commissure line and to the midline; then the Acc contours were traced and its dimensions and 3D stereotactic coordinates measured, on each slice. Finally a 3D computerized model was created.
RESULTS: The human Acc was identified as a distinct brain structure, with clear-cut limits on its posterior half. It lies parallel to the midline, descends caudally, and progresses from a globose to a flattened and dorsolateral concave shape. Its main expression is subcomissural.
CONCLUSION: This study defined more accurately the 3D anatomy of the human Acc, providing new tools for stereotactic procedures.

Entities:  

Mesh:

Year:  2013        PMID: 23913108     DOI: 10.1007/s00701-013-1820-z

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

1.  Postmortem volumetric analysis of the nucleus accumbens in male heroin addicts: implications for deep brain stimulation.

Authors:  Ulf J Müller; Kurt Truebner; Kolja Schiltz; Jens Kuhn; Christian Mawrin; Henrik Dobrowolny; Hans-Gert Bernstein; Bernhard Bogerts; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-07-19       Impact factor: 5.270

2.  Modeling nucleus accumbens : A Computational Model from Single Cell to Circuit Level.

Authors:  Rahmi Elibol; Neslihan Serap Şengör
Journal:  J Comput Neurosci       Date:  2020-11-09       Impact factor: 1.621

3.  Ganser-like syndrome after loss of psychic self-activation syndrome: psychogenic or organic?

Authors:  Elsa Kaphan; Emmanuel Barbeau; Marie L Royère; Eric Guedj; Jean Pelletier; André Ali Chérif
Journal:  Arch Clin Neuropsychol       Date:  2014-10-03       Impact factor: 2.813

4.  The intranuclear length of the electrode trajectory according to the 'port' model for deep brain stimulation of the nucleus accumbens.

Authors:  Ioannis N Mavridis
Journal:  Ann Transl Med       Date:  2018-02

5.  Target-specific deep brain stimulation of the ventral capsule/ventral striatum for the treatment of neuropsychiatric disease.

Authors:  Chencheng Zhang; Dianyou Li; Haiyan Jin; Kristina Zeljic; Bomin Sun
Journal:  Ann Transl Med       Date:  2017-10

6.  The Retrograde Connections and Anatomical Segregation of the Göttingen Minipig Nucleus Accumbens.

Authors:  Anders C Meidahl; Dariusz Orlowski; Jens C H Sørensen; Carsten R Bjarkam
Journal:  Front Neuroanat       Date:  2016-12-05       Impact factor: 3.856

Review 7.  The Dopamine System and Automatization of Movement Sequences: A Review With Relevance for Speech and Stuttering.

Authors:  Per A Alm
Journal:  Front Hum Neurosci       Date:  2021-12-02       Impact factor: 3.169

8.  Neurobiology of loneliness: a systematic review.

Authors:  Jeffrey A Lam; Emily R Murray; Kasey E Yu; Marina Ramsey; Tanya T Nguyen; Jyoti Mishra; Brian Martis; Michael L Thomas; Ellen E Lee
Journal:  Neuropsychopharmacology       Date:  2021-07-06       Impact factor: 7.853

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.